etoposide 20 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
gemcitabine 2 g powder for solution for infusion
fresenius kabi oncology plc - gemcitabine - powder for solution for infusion - 2 gram(s) - pyrimidine analogues; gemcitabine
gemcitabine 200 mg powder for solution for infusion
fresenius kabi oncology plc - gemcitabine - powder for solution for infusion - 200 milligram(s) - pyrimidine analogues; gemcitabine
gemcitabine 40mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - gemcitabine hydrochloride - concentrate for solution for infusion - 40 milligram(s)/millilitre - pyrimidine analogues; gemcitabine
gemcitabine 1 g powder for solution for infusion
fresenius kabi oncology plc - gemcitabine - powder for solution for infusion - 1 gram(s) - pyrimidine analogues; gemcitabine
irinotecan hydrochloride 20 mg/ml concentrate for
fresenius kabi oncology plc - irinotecan hydrochloride trihydrate - solution for infusion - 20 micromol - irinotecan
oxaliplatin 5mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - oxaliplatin - concentrate for solution for infusion - 5 milligram(s)/millilitre - platinum compounds; oxaliplatin
paclitaxel 6 mg/ml concentrate for solution for infusion
fresenius kabi limited - paclitaxel - concentrate for solution for infusion - 6 milligram(s)/millilitre - taxanes; paclitaxel
gemcitabine 38mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - gemcitabine hydrochloride - concentrate for solution for infusion - 38 milligram(s)/millilitre - pyrimidine analogues; gemcitabine
linezolid 2 mg/ml solution for infusion
fresenius kabi limited - linezolid - solution for infusion - 2 mg/ml - other antibacterials